Please login to the form below

Not currently logged in
Email:
Password:

Newron Pharma

This page shows the latest Newron Pharma news and features for those working in and with pharma, biotech and healthcare.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US

Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in

Latest news

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015’

    In 2015, a total of 44 New Molecular Entities (NMEs) were approved for marketing in countries around the world, maintaining the high output from pharma industry pipelines of the last few ... neprilysin inhibitor. Novartis. USA. safinamide. Xadago.

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    Generic versions of this drug combination are also available, including Parcopa (Azur Pharma). ... Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Newron Pharma appoints commercial affairs VP Newron Pharma appoints commercial affairs VP

    Newron Pharma appoints commercial affairs VP. Dennis Dionne brings expertise from J&J and Novartis. ... Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics